Fig. 1From: What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the pastThe roadmap of IDO1 inhibitor development. IDO1 indoleamine 2,3-dioxygenase 1. PD-1 programmed death receptor 1Back to article page